• No results found

Genetics, autoantibodies and clinical features in understanding and predicting rheumatoid arthritis Helm-van Mil, A.H.M. van der

N/A
N/A
Info
Downloaden
Protected

Academic year: 2021

Share "Genetics, autoantibodies and clinical features in understanding and predicting rheumatoid arthritis Helm-van Mil, A.H.M. van der"

Copied!
2
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Download het nu ( 2 pagina )

Hele tekst

(1)

Genetics, autoantibodies and clinical features in understanding and predicting rheumatoid arthritis

Helm-van Mil, A.H.M. van der

Citation

Helm-van Mil, A. H. M. van der. (2006, October 26). Genetics, autoantibodies and clinical features in understanding and predicting

rheumatoid arthritis. Retrieved from https://hdl.handle.net/1887/4929

Version: Corrected Publisher’s Version

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden

Downloaded

from: https://hdl.handle.net/1887/4929

(2)

GENETICS,

AUTOANTIBODIES

AND CLINICAL

FEATURES IN

UNDERSTANDING

AND PREDICTING

RHEUMATOID

ARTHRITIS

A.H.M. van der Helm

– van Mil

GE NE TI CS, A UTO ANTI BO DIE S A ND C LIN IC AL F EA TU RE S I N U ND ER ST AN DIN G A ND P RE DIC TI NG R HE UM ATO ID A RTH RITI S

Referenties

Download het nu ( PDF - 2 pagina - 170.29 KB )

GERELATEERDE DOCUMENTEN

Genetics, autoantibodies and clinical features in understanding and predicting rheumatoid arthritis

$2"¬ TYPING¬ WAS¬ PERFORMED¬ IN¬ ¬ 2!¬ PATIENTS¬ FROM¬ THE¬ ,EIDEN¬ %ARLY¬ !RTHRITIS¬ #LINIC¬ THE¬ ,EIDEN¬ %!#¬ A¬ $UTCH¬ POPULATION BASED¬ INCEPTION¬ COHORT¬

Genetics, autoantibodies and clinical features in understanding and predicting rheumatoid arthritis

$2¬IS¬ASSOCIATED¬WITH¬ANTI ##0 NEGATIVE¬ARTHRITIS¬AND¬NOT¬WITH¬ANTI ##0 POSITIVE¬ ARTHRITIS¬ 4HESE¬ DATA¬ SHOW¬ THAT¬ DISTINCT¬ GENETIC¬ RISK¬ FACTORS¬ ARE¬

Genetics, autoantibodies and clinical features in understanding and predicting rheumatoid arthritis

¬IT¬WAS¬OBSERVED¬BY¬TWO¬DIFFERENT¬ METHODS¬ LINKAGE¬ AND¬ ASSOCIATION¬ ANALYSIS ¬ THAT¬ THE¬ 3% ALLELES¬ ARE¬ ONLY¬ A¬ RISK¬ FACTOR¬ FOR¬ 2!¬ THAT¬ IS¬

Genetics, autoantibodies and clinical features in understanding and predicting rheumatoid arthritis

WERE¬ PROMPTLY¬ TREATED¬ WITH¬ EITHER¬ METHOTREXATE¬ OR¬ SALAZOPYRINE¬ EARLY¬ TREATMENT ¬ 4HE¬

Genetics, autoantibodies and clinical features in understanding and predicting rheumatoid arthritis

)N¬CONCLUSION ¬THE¬PRESENT¬STUDY¬OBSERVED¬AFTER¬CORRECTION¬FOR¬DIFFERENCES¬IN¬DISEASE¬DURA TION¬ AND¬ AUTOANTIBODY¬ STATUS¬ AN¬ INCREASE¬ IN¬ VARIATION¬

Genetics, autoantibodies and clinical features in understanding and predicting rheumatoid arthritis

MODELS¬ THAT¬ TAKE¬ INTO¬ ACCOUNT¬ BOTH¬ GENETIC¬ AND¬ CLINICAL¬ CHARACTERISTICS¬ WILL¬ HAVE¬ TO¬ BE EVALUATED¬ IN¬ PATIENT¬ GROUPS¬ WITH¬ UNDIFFERENTIATED¬

Genetics, autoantibodies and clinical features in understanding and predicting rheumatoid arthritis

LOGISTIC¬ REGRESSION¬ ANALYSES¬ REVEALED¬ THAT¬ ARTHRITIS¬ OF¬ THE¬ LARGE¬ JOINTS ¬ IN¬ PARTICULAR¬ THE¬ KNEE

Genetics, autoantibodies and clinical features in understanding and predicting rheumatoid arthritis

/F¬ ¬ 5! PATIENTS ¬ ¬ DEVELOPED¬ 2!¬ DURING¬ THE¬ l¬RST¬ YEAR¬ OF¬ FOLLOW UP ¬ ¬ PATIENTS¬ DEVELOPED¬ OTHER¬ RHEUMATOLOGICAL¬ DISEASES ¬ ¬ PATIENTS¬